Istanbul Universitesi Cerrahpasa-Medical Oncology

Site:	Istanbul Universitesi Cerrahpasa-Medical Oncology
Address:
City:	Istanbul
State:
Zip:	34668
Country:	Turkey

Phase	Trial [desc]	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Closed	Belzutifan	NCT04924075